Global Oncology Academy
The Global Oncology Academy (GOA) is an educational platform for physicians and other healthcare professionals involved in oncology. Its mission is to increase knowledge regarding the disease course of specific cancers and address key elements for successful management. The GOA series will also share the science around innovations in combination therapies, oncology strategies, and new developments.
For more information about GOA, visit www.globaloncologyacademy.org.
Episodes 16-30 of 151
Prostate Cancer Care: Testosterone Therapy’s Impact on Biochemical Recurrence
On the Frontlines of Prostate CancerProstate Cancer Care: Testosterone Therapy’s Impact on Biochemical Recurrence
Examining the Role of Bacterial Biofilms in Colorectal Cancer Screening
Clinician's RoundtableExamining the Role of Bacterial Biofilms in Colorectal Cancer Screening
Slowing Prostate Cancer Progression: The Role of Dietary Fat Modifications
On the Frontlines of Prostate CancerSlowing Prostate Cancer Progression: The Role of Dietary Fat Modifications
Early-Stage Prostate Cancer Treatment: Examining Long-Term Complications
On the Frontlines of Prostate CancerEarly-Stage Prostate Cancer Treatment: Examining Long-Term Complications
Advancing Cancer Care: Key Considerations for Subcutaneous Immunotherapies
Project Oncology®Advancing Cancer Care: Key Considerations for Subcutaneous Immunotherapies
Screening Modalities for Colon Cancer: What You Need to Know
GI InsightsScreening Modalities for Colon Cancer: What You Need to Know
Etranacogene Dezaparvovec for Hemophilia B: Efficacy and Safety Four Years Post-Infusion
Clinician's RoundtableEtranacogene Dezaparvovec for Hemophilia B: Efficacy and Safety Four Years Post-Infusion
An Analysis of Subcutaneous Versus Intravenous Atezolizumab in NSCLC
Spotlight On Subcutaneous Cancer ImmunotherapiesAn Analysis of Subcutaneous Versus Intravenous Atezolizumab in NSCLC
Unresectable Hepatocellular Carcinoma Care: Investigating a Combination Therapy
Project Oncology®Unresectable Hepatocellular Carcinoma Care: Investigating a Combination Therapy
Nanrilkefusp Alfa: A Promising Subcutaneous IL-15Rβγ Superagonist
Spotlight On Subcutaneous Cancer ImmunotherapiesNanrilkefusp Alfa: A Promising Subcutaneous IL-15Rβγ Superagonist
AML Care: Examining the Efficacy and Safety of a Triplet Combination Therapy
Project Oncology®AML Care: Examining the Efficacy and Safety of a Triplet Combination Therapy
Evaluating Alemtuzumab in Adult ALL: Insights from a Phase 1/2 Clinical Trial
Spotlight On Subcutaneous Cancer ImmunotherapiesEvaluating Alemtuzumab in Adult ALL: Insights from a Phase 1/2 Clinical Trial
Advancing Multiple Myeloma Treatment: The Role of Immunotherapy and Personalized Care
Project Oncology®Advancing Multiple Myeloma Treatment: The Role of Immunotherapy and Personalized Care
The Impact of a Plant-Based Diet on Multiple Myeloma Prevention and Progression
Project Oncology®The Impact of a Plant-Based Diet on Multiple Myeloma Prevention and Progression
Establishing D-VRd Efficacy for Transplant-Ineligible Multiple Myeloma
Project Oncology®Establishing D-VRd Efficacy for Transplant-Ineligible Multiple Myeloma
